Hanx Biopharmaceuticals (Wuhan) Co., Ltd. announced that, effective 2 June 2026, its principal place of business in Hong Kong has been relocated to Room 1918, 19/F, Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong.
The company confirmed that its telephone number, email address and website remain unchanged following the move.
The announcement was authorised by the Board of Directors and signed by Chairman and Executive Director Dr. Zhang Faming on the date of the notice.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments